FRA:R66

Phillips 66 Stock Signals

etoro logo Buy R66
*Your capital is at risk
119.36€
-3.66 (-2.98%)
At Close: Nov 17, 2025

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.883 14 days ( -2.63 % )
Last Price 119.36€ -2.98 %
High/ Low 119.36€ - 119.36€ 0.0335%
Chg 7 Days 0.0335 % $119.32 119.36€
Chg 30 Days 7.55 % $110.98 119.36€
Chg 12 mos -2.77 % $122.76 119.36€
Trend - 3 mos 7.33 % Width: 7.97 %
Trend - 12 mos -10.31 % Width: 63.65 %
Pred. range - 3 mos 122.46€ - 132.21€ 2.59 % - 10.77 %
Pred. range - 12 mos 67.39€ - 110.28€ -43.54 % - -7.61 %
Short MA avg 3 mos Sell Nov 14, 2025 - 2 days
Long MA avg 3 mos Buy Oct 23, 2025 - 18 days
Short/Long MA avg 3 mos Buy Oct 27, 2025 - 16 days
Short MA avg 12 mos Buy Oct 23, 2025 - 18 days
Long MA avg 12 mos Buy Jul 29, 2025 - 53 days
Short/Long MA avg 12 mos Buy Sep 10, 2025 - 49 days
Pivot Short Sell Nov 14, 2025 - 2 days
Bollinger Buy Oct 30, 2025 - 13 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!
ABOUT PHILLIPS 66
Phillips 66
Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE